Evaluation of the cholinergic hypothesis in Alzheimer’s disease with neuropsychological methods

Aging Clinical and Experimental Research

Volumn 27, Issue 5, 2015, Pages 727-733

  Fotiou, Dimitrios ^a   Kaltsatou, Antonia ^a,b   Tsiptsios, Dimitrios ^a   Nakou, Maria ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY OF THESSALY   (Greece)

Author keywords

Alzheimer s disease; Cholinergic hypothesis; Cognitive function; Neuropsychological methods; Pupillometry

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; CHOLINERGIC SYSTEM; CLINICAL ARTICLE; COGNITION ASSESSMENT; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; FEMALE; HAMILTON DEPRESSION RATING SCALE; HUMAN; HYPOTHESIS; MALE; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGY; PUPILLOMETRY; WECHSLER MEMORY SCALE; COGNITION; COGNITION DISORDERS; INTELLIGENCE TEST; MEMORY; METABOLISM; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PHYSIOLOGY; PSYCHOLOGY; PUPIL REFLEX; STATISTICS; SYNAPTIC TRANSMISSION;

ACETYLCHOLINE; CHOLINERGIC RECEPTOR STIMULATING AGENT; NORADRENALIN;

ACETYLCHOLINE; AGED; ALZHEIMER DISEASE; CHOLINERGIC AGENTS; COGNITION; COGNITION DISORDERS; DEPRESSION; FEMALE; HUMANS; INTELLIGENCE TESTS; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; NOREPINEPHRINE; REFLEX, PUPILLARY; STATISTICS AS TOPIC; SYNAPTIC TRANSMISSION;

EID: 84941345832     PISSN: 15940667     EISSN: 17208319     Source Type: Journal    
DOI: 10.1007/s40520-015-0321-8     Document Type: Article

References (43)

1. Association Alzheimer’s (2014) Alzheimer’s disease facts and figures. Alzheimer’s Dement 10(2):e47–e92
2. Francis PT, Palmer AM, Snape M et al (1999) The cholinergic hypothesis of Alzheimer’s disease: a review of progress. J Neurol Neurosurg Psychiatry 66(2):137–147
3. Tsolaki M, Paraskevi S, Degleris N et al (2009) Attitudes and perceptions regarding Alzheimer’s disease in Greece. Am J Alzheimers Dis Other Demen 24(1):21–26
4. Tanimukai H, Kudo T, Tanaka T et al (2009) Novel therapeutic strategies for neurodegenerative disease. Psychogeriatrics 9(2):103–109
5. Craig-Schapiro R, Kuhn M, Xiong CJ et al (2011) Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer’s disease diagnosis and prognosis. PLoS One 6(4):e18850
6. Bartus RT, Dean RL 3rd, Beer B et al (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217(4558):408–414
7. Bartus RT (2000) On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis. Exp Neurol 163(2):495–529
8. Contestabile A (2011) The history of the cholinergic hypothesis. Behav Brain Res 221(2):334–340
9. Trick GL, Barris MC, Bickler-Bluth M (1989) Abnormal pattern electroretinograms in patients with senile dementia of the Alzheimer type. Ann Neurol 26(2):226–231
10. Aharon-Peretz J, Harel T, Revach M et al (1992) Increased sympathetic and decreased parasympathetic cardiac innervation in patients with Alzheimer’s disease. Arch Neurol 49(9):919–922
11. Appleyard ME, McDonald B (1991) Reduced adrenal gland acetylcholinesterase activity in Alzheimer’s disease. Lancet 338(8774):1085–1086
12. Fotiou F, Fountoulakis KN, Tsolaki M et al (2000) Changes in pupil reaction to light in Alzheimer’s disease patients: a preliminary report. Int J Psychophysiol 37(1):111–120
13. Jack CR Jr, Knopman DS, Jagust WJ et al (2010) Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade. Lancet Neurol 9(1):119–128
14. Tsolaki M, Fountoulakis K, Chantzi E et al (1997) Risk factors for clinically diagnosed Alzheimer’s disease: a case-control study of a Greek population. Int Psychogeriatr 9(3):327–341
15. Fountoulakis KN, Tsolaki M, Mohs RC et al (1998) Epidemiological dementia index: a screening instrument for Alzheimer’s disease and other types of dementia suitable for use in populations with low education level. Dement Geriatr Cogn Disord 9(6):329–338
16. Ascher KW (1962) The first pupillary light reflex test ever performed. Trans Am Ophthalmol Soc 60:53–59
17. Ascher KW (1963) The first test of the pupillary reflex to light. Boll Ocul 42:586–591
18. Thompson HS (1977) Adie’s syndrome: some new observations. Trans Am Ophthalmol Soc 75:587–626
19. Idiaquez J (1984) Short-term prognostic factors in cerebrovascular accident. Rev Med Chil 112(6):544–546
20. Pomara N, Sitaram N (1995) Detecting Alzheimers-disease. Science 267(5204):1579–1580
21. Scinto LF, Daffner KR, Dressler D et al (1994) A potential noninvasive neurobiological test for Alzheimer’s disease. Science 266(5187):1051–1054
22. Loupe DN, Newman NJ, Green RC et al (1996) Pupillary response to tropicamide in patients with Alzheimer disease. Ophthalmology 103(3):495–503
23. Treloar AJ, Assin M, Macdonald AJ (1996) Pupillary response to topical tropicamide as a marker for Alzheimer’s disease. Br J Clin Pharmacol 41(3):256–257
24. Kardon RH (1998) Drop the Alzheimer’s drop test. Neurology 50(3):588–591
25. Marx JL, Kumar SR, Thach AB et al (1995) Detecting Alzheimer’s disease. Science 267(5204):1577 (author reply 1580-1)
26. Sacks B, Smith S (1989) People with Down’s syndrome can be distinguished on the basis of cholinergic dysfunction. J Neurol Neurosurg Psychiatry 52(11):1294–1295
27. Prettyman R, Bitsios P, Szabadi E (1997) Altered pupillary size and darkness and light reflexes in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 62(6):665–668
28. Altman E, Gilmore C, Peterson J et al (1991) Psychiatric rating scales in diagnostic assessment and clinical treatment. Psychiatr Med 9(1):189–211
29. Tsiptsios D, Fotiou DF, Haidich AB et al (2008) Evaluation of pupil mobility in patients with myasthenia gravis. Electromyogr Clin Neurophysiol 48(5):209–218
30. Bergamin O, Schoetzau A, Sugimoto K et al (1998) The influence of iris color on the pupillary light reflex. Graefes Arch Clin Exp Ophthalmol 236(8):567–570
31. Kaltsatou A, Kouidi E, Fotiou D et al (2011) The use of pupillometry in the assessment of cardiac autonomic function in elite different type trained athletes. Eur J Appl Physiol 111(9):2079–2087
32. Stergiou V, Fotiou D, Tsiptsios D et al (2009) Pupillometric findings in patients with Parkinson’s disease and cognitive disorder. Int J Psychophysiol 72(2):97–101
33. Fountoulakis KN, Tsolaki M, Chantzi H et al (2000) Mini Mental State Examination (MMSE): a validation study in Greece. Am J Alzheimers Dis Other Demen 15(6):342–345
34. Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189–198
35. Efklides A, Yiultsi E, Kangellidou T et al (2002) Wechsler memory scale, Rivermead behavioral memory test, and everyday memory questionnaire in healthy adults and Alzheimer patients. Eur J Psychol Assess 18(1):63–77
36. Fava GA, Kellner R, Munari F et al (1982) The Hamilton depression rating scale in normals and depressives. Acta Psychiatr Scand 66(1):26–32
37. Cohen J (1992) A power primer. Psychol Bull 112(1):155–159
38. Davies P, Maloney AJ (1976) Selective loss of central cholinergic neurons in Alzheimer’s disease. Lancet 2(8000):1403
39. Bowen DM, Smith CB, White P et al (1976) Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain 99(3):459–496
40. Piha SJ, Halonen JP (1994) Infrared pupillometry in the assessment of autonomic function. Diabetes Res Clin Pract 26(1):61–66
41. Granholm E, Steinhauer SR (2004) Pupillometric measures of cognitive and emotional processes. Int J Psychophysiol 52(1):1–6
42. Paul RH, Cohen RA, Gilchrist JM et al (2000) Cognitive dysfunction in individuals with myasthenia gravis. J Neurol Sci 179(S 1–2):59–64
43. Perry E, Walker M, Grace J et al (1999) Acetylcholine in mind: a neurotransmitter correlate of consciousness? Trends Neurosci 22(6):273–280